IDH1 and astrocytoma (excluding glioblastoma): Histological investigations confirmed a WHO Grade II Astrocytoma (MGMT promoter methylated, IDH1-mutated; absence of 1p/19q deletion; ki-67 index: 4%; Fig. 2, A1–3).